Molecular and clinical risk markers in colon cancer trials

European Journal of Cancer

Volumn 36, Issue 10, 2000, Pages 1288-1291

  Hill, M J ^a  

^a WEXHAM PARK HOSPITAL   (United Kingdom)

Author keywords

Chemoprevention; Clinical risk factors; Colorectal cancer; Molecular risk factors; Polymorphisms

Indexed keywords

ACYLTRANSFERASE; MARKER;

ANAMNESIS; CANCER PREVENTION; CANCER RISK; CLINICAL TRIAL; COLON ADENOMA; COLORECTAL CANCER; CONFERENCE PAPER; ENTERITIS; FOLLOW UP; GENETIC MARKER; GENETIC POLYMORPHISM; HUMAN; PATIENT SELECTION; PRIORITY JOURNAL; RISK FACTOR; SAMPLE;

ADENOMA; ADENOMATOUS POLYPOSIS COLI; CLINICAL TRIALS; COLORECTAL NEOPLASMS; FEMALE; GENETIC MARKERS; HUMANS; MALE; MUTATION; PRECANCEROUS CONDITIONS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034084323     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00109-X     Document Type: Conference Paper

References (26)

1. Hill MJ. Microbes and Human Carcinogenesis. London, Edward Arnold, 1986.
2. Morson BC, Bussey HJR, Day DW, Hill MJ. Adenomas of the large bowel. Cancer Surveys 1983, 2, 2451-2478.
3. Morson BC. The polyp-cancer sequence in the large bowel. Proc Roy Soc Med 1974, 67, 451-457.
4. Konishi K, Fujii T, Boku N, et al. Clinicopathological differences between colonie and rectal carcinomas: are they based on the same mechanism of carcinogenesis? Gut 1999, 45, 818-821.
5. Jass JR. Colon cancer: the shape of things to come. Gut 1999, 45, 794-795.
6. Hill MJ. Metabolic epidemiology of large bowel cancer. In DeCosse JJ, Sherlock P, eds. Gastrointestinal Cancer. The Hague, Martinus Nijhoff, 1981, 187-226.
7. Cole JW, Holden WD. Post-colectomy regression of adenomatous polyps in the human colon. Arch Surg 1959, 79, 385-392.
8. Hill MJ, Morson BC, Bussey HJR. Aetiology of the adenomacarcinoma sequence in the large bowel. Lancet 1978, i, 535-538.
9. MacDougall IPM. Clinical identification of those cases of ulcerative colitis most likely to develop cancer of the bowel. Dis Colon Rectum 1964, 7, 447-450.
10. Bussey HJR. Familial Polyposis Coli. Baltimore, John Hopkins University Press, 1975.
11. DeCosse JJ, Bussey HJR, Thomson JPS, et al. Ascorbic acid in polyposis coli. In Winawer S, Schottenfeld D, Sherlock P, eds. Colorectal Cancer: Prevention, Epidemiology and Screening. Raven Press, 1980, 59-64.
12. MacLennan R, Macrae F, Bain C, et al. Randomised trial of intake of fat, fiber and beta carotene to prevent colorectal adenomas. The Australian National Polyp Prevention Project. J Natl Cancer Inst 1995, 87, 1760-1766.
13. Fearon ER, Vogelstein B. A genetic model for colorectal carcinogenesis. Cell 1990, 61, 759-767.
14. Martin L, Assem M, Piard F. Are there different types of colorectal cancers? Correlations with the genetic data. Eur J Cancer Prev 1999, 8(Suppl. 1), S13-S20.
15. Olschwang S. Germline mutation and genome instability. Eur J Cancer Prev 1999, 8(Suppl. 1), S33-S38.
16. Freedman AN, Michalek AM, Muro K, et al. Meat consumption is associated with K-ras mutation in tumours of the distal rectum. Proc AACR 1997, 38, 457A.
17. Bartsch H, Malaveille C, Lowenfels AB, Maisonneuve P, Hautefeuille A, Boyle P. Genetic polymorphism of N-acetyltransferases, glutathione transferase Ml and NAP(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk. Eur J Cancer Prev 1998, 7, 215-223.
18. Vineis P. Epidemiological models of carcinogenesis; the example of bladder cancer. Cancer Epidem Biomarkers Prev 1992, 1, 149-153.
19. Lang NP, Butler MA, Massengill J, et al. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to foodborne heterocyclic amines increase the risk of colorectal cancer or polyps. Cancer Epidem Biomarkers Prev 1994, 3, 675-682.
20. Roberts-Thomson 1C, Butler WJ, Ryan P. Meat, metabolic genotypes and risk of colorectal cancer. Eur J Cancer Prev 1999, 8, 207-211.
21. Slattery ML, Potter JD, Ma K-N, Caan BJ, Leppert M, Samowitz W. Western diet, family history of colorectal cancer, NAT2, GSTM-1 and risk of colon cancer. Cancer Causes and Control2000, 11, 1-8.
22. Little J, Faivre J. Family history, metabolic gene polymorphism, diet and the risk of colorectal cancer. Eur J Cancer Prev 1999, 8(Suppl. 1), S61-S72.
23. Giovannucci E, Stampfer MJ, Colditz GA, et al. Folate, methionine and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 1993, 85, 875-884.
24. Giovannucci E, Rimm EB, Ascherio A, et al. Alcohol, lowmethionine-low-folate diets, and risk of colorectal cancer in men. J Natl Cancer Inst 1995, 87, 265-273.
25. Ma J, Stampfer MJ, Giovannucci E, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997, 57, 1098-1102.
26. Slattery ML, Schaffer D, Edwards SL, Ma KN, Potter JD. Are dietary factors involved in DNA methylation associated with colon cancer? Nutr Cancer 1997, 28, 52-62.